tiprankstipranks

David Shapiro. Insider Profile

11 Followers
David Shapiro., CMO at Intercept Pharma, holds 39.50K shares in Intercept Pharma (Ticker: ICPT), holds ― shares in Organovo Holdings (Ticker: ONVO), holds ― shares in Galecto (Ticker: GLTO).
tipranks
David Shapiro.

David Shapiro.
Intercept Pharma (ICPT)
CMO

Ranked #8,824 out of 98,909 Corporate Insiders

Profitable Transactions

89%
8 out of 9 Profitable Transactions

Average Return

+19.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

David Shapiro. does not currently own shares as a corporate insider.
A breakdown of David Shapiro.'s holdings

Insider Roles

Organovo Holdings
(ONVO)
Director
Galecto
(GLTO)
Director
Roles that David Shapiro. holds in companies

Most Profitable Insider Trade

Stock:
Intercept Pharma
(ICPT)
Rating:Informative Sell
Date:Jan 05, 2017 - Jan 05, 2018
Return:+44.90%
The most profitable trade made by David Shapiro.

David Shapiro.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ICPT
Intercept Pharma
May 03, 2019
Uninformative Sell
172.56K
$750.48K
Organovo Holdings
Director
Galecto
Director
List of latest transactions for each holding click on a transaction to see David Shapiro.'s performance on stock

David Shapiro. insider profile FAQ

What is the percentage of profitable transactions made by David Shapiro.?
The percentage of profitable transactions made by David Shapiro. is 89%.
    What is the average return per transaction made by David Shapiro.?
    The average return per transaction made by David Shapiro. is 19.90%.
      What stocks does David Shapiro. hold?
      David Shapiro. holds: ICPT, ONVO, GLTO stocks.
        What was David Shapiro.’s latest transaction?
        David Shapiro. latest transaction was an Uninformative Sell of $172.56K.
          What was David Shapiro.'s most profitable transaction?
          David Shapiro.’s most profitable transaction was an Informative Sell of ICPT stock on January 5, 2017. The return on the trade was 44.90%.
            What is David Shapiro.'s role in Intercept Pharma?
            David Shapiro.'s role in Intercept Pharma is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.